Mackenzie Financial Corp Glaukos Corp Transaction History
Mackenzie Financial Corp
- $66.8 Billion
- Q3 2024
A detailed history of Mackenzie Financial Corp transactions in Glaukos Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,160 shares of GKOS stock, worth $438,039. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,160
Previous 2,842
11.19%
Holding current value
$438,039
Previous $336,000
22.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GKOS
# of Institutions
336Shares Held
47MCall Options Held
126KPut Options Held
184K-
Black Rock Inc. New York, NY8.04MShares$1.11 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$814 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$303 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$271 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$227 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.6B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...